Title: An Act to Expand Access and Reduce Barriers to Access to Naloxone
Official Title: An Act to Expand Access and Reduce Barriers to Access to Naloxone
Number of Sections: 3
Source: versions - Final Disposition
Media Type: application/pdf
Strikethrough Detection: 3 sections found

================================================================================

Section 1:
APPROVED CHAPTER
MAY 29, 2025 145
BY GOVERNOR PUBLIC LAW
STATE OF MAINE
_____
IN THE YEAR OF OUR LORD
TWO THOUSAND TWENTY-FIVE
_____
H.P. 449 - L.D. 710
Hydrochloride and Other Opioid Overdose-reversing Medications
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 22 MRSA §2353, sub-§2, as amended by PL 2023, c. 161, §3, is further
amended to read:

Section 2:
2. Prescription; possession; administration. The prescription, possession and
administration of naloxone hydrochloride or another opioid overdose-reversing medication
is governed by this subsection.
A. A health care professional may directly or by standing order prescribe naloxone
hydrochloride or another opioid overdose-reversing medication to an individual at risk
of experiencing an opioid-related drug overdose. Over-the-counter naloxone
hydrochloride or another opioid overdose-reversing medication approved for over-the-
counter dispensation by the federal Food and Drug Administration or its successor
organization may be provided or administered with or without a prescription.
A-1. A pharmacist may prescribe and dispense naloxone hydrochloride or another
opioid overdose-reversing medication in accordance with protocols established under
Title 32, section 13815 to an individual of any age at risk of experiencing an opioid-
related drug overdose. Over-the-counter naloxone hydrochloride or another opioid
overdose-reversing medication approved for over-the-counter dispensation by the
federal Food and Drug Administration or its successor organization may be provided
or administered with or without a prescription.
B. An individual to whom naloxone hydrochloride or another opioid overdose-
reversing medication is prescribed or dispensed in accordance with paragraph A or A‑1
may provide the naloxone hydrochloride or another opioid overdose-reversing
medication so prescribed or dispensed to a member of that individual's immediate
family to possess and administer to the individual if the family member believes in
good faith that the individual is experiencing an opioid-related drug overdose.
C. A health care professional may directly or by standing order prescribe naloxone
hydrochloride or another opioid overdose-reversing medication to a member of an
Page 1 - 132LR0267(03)
individual's immediate family or a friend of the individual or to another person in a
position to assist the individual if the individual is at risk of experiencing an opioid-
related drug overdose. Over-the-counter naloxone hydrochloride or another opioid
overdose-reversing medication approved for over-the-counter dispensation by the
federal Food and Drug Administration or its successor organization may be provided
or administered with or without a prescription.
C-1. A pharmacist may prescribe and dispense naloxone hydrochloride or another
opioid overdose-reversing medication in accordance with protocols established under
Title 32, section 13815 to a person of any age who is a member of an individual's
immediate family or a friend of the individual or to another person in a position to assist
the individual if the individual is at risk of experiencing an opioid-related drug
overdose. Over-the-counter naloxone hydrochloride or another opioid overdose-
reversing medication approved for over-the-counter dispensation by the federal Food
and Drug Administration or its successor organization may be provided or
administered with or without a prescription.
D. If a member of an individual's immediate family, friend of the individual or other
person is prescribed or provided naloxone hydrochloride or another opioid overdose-
reversing medication in accordance with paragraph C or C‑1, that family member,
friend or other person may administer the naloxone hydrochloride or another opioid
overdose-reversing medication to the individual if the family member, friend or other
person believes in good faith that the individual is experiencing an opioid-related drug
overdose.
Nothing in this subsection affects the provisions of law relating to maintaining the
confidentiality of medical records.
Sec. 2. 22 MRSA §2353, sub-§4, as amended by PL 2023, c. 71, §1 and c. 161, §3,
is further amended to read:

Section 3:
4. Community-based drug overdose prevention programs; standing orders for
naloxone hydrochloride or another opioid overdose-reversing medication. Acting
under standing orders from a licensed health care professional authorized by law to
prescribe naloxone hydrochloride or another opioid overdose-reversing medication, a
public health an agency that provides services to populations at high risk for a drug
overdose may establish an overdose prevention program in accordance with rules adopted
by the department and the provisions of this subsection.
A. Notwithstanding any provision of law to the contrary, an overdose prevention
program established under this subsection may store and dispense naloxone
hydrochloride or another opioid overdose-reversing medication without being subject
to the provisions of Title 32, chapter 117 as long as these activities are undertaken
without charge or compensation.
B. An overdose prevention program established under this subsection may distribute
unit-of-use packages of naloxone hydrochloride or another opioid overdose-reversing
medication and the medical supplies necessary to administer the naloxone
hydrochloride or another opioid overdose-reversing medication to a person who has
successfully completed training provided by the overdose prevention program that
meets the protocols and criteria established by the department, so that the person may
possess and administer naloxone hydrochloride or another opioid overdose-reversing
Page 2 - 132LR0267(03)
medication to an individual who appears to be experiencing an opioid-related drug
overdose.
C. With the express consent of a municipality, an overdose prevention program
established under this subsection may provide and maintain naloxone hydrochloride or
another opioid overdose-reversing medication in a wall-mounted box or other visible
and accessible container, including, but not limited to, a vending machine, on publicly
accessible property of the municipality, including a municipal building, public
restroom, public library or public park or recreational facility, for use by a member of
the public in response to an opioid-related drug overdose.
The department shall adopt rules to implement this subsection. Rules adopted pursuant to
this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter
2‑A.
Sec. 3. 22 MRSA §2353, sub-§4-A, ¶B, as amended by PL 2023, c. 161, §3, is
repealed.
Sec. 4. 22 MRSA §2353, sub-§4-A, ¶C, as amended by PL 2023, c. 161, §3, is
further amended to read:
C. A licensed health care professional authorized by law to prescribe naloxone
hydrochloride or another opioid overdose-reversing medication shall distribute unit-
of-use packages of naloxone hydrochloride or another opioid overdose-reversing
medication and any medical supplies necessary to administer the naloxone
hydrochloride or another opioid overdose-reversing medication to a recovery residence
that has provided training described in paragraph B so that the recovery residence may
possess and administer naloxone hydrochloride or another opioid overdose-reversing
medication to an individual who appears to be experiencing a drug-related overdose.
Sec. 5. 22 MRSA §2353, sub-§5, ¶C, as enacted by PL 2023, c. 71, §2, is amended
to read:
C. A municipality or overdose prevention program is immune from criminal and civil
liability for providing or maintaining naloxone hydrochloride containers or containers
of another opioid overdose-reversing medication under subsection 4, paragraph C.
Sec. 6. 22 MRSA §2353, sub-§5, ¶D, as enacted by PL 2023, c. 154, §2, is
amended to read:
D. A person not described in this section as being authorized to possess, obtain, store,
administer or dispense naloxone hydrochloride or another opioid overdose-reversing
medication or a person, notwithstanding any provision of law to the contrary, acting in
good faith and with reasonable care, is immune from criminal and civil liability and is
not subject to professional or other disciplinary action for providing to another person
naloxone hydrochloride or another opioid overdose-reversing medication, or for
administering naloxone hydrochloride or another opioid overdose-reversing
medication to an individual whom the person believes in good faith is experiencing an
opioid-related drug overdose or for any outcome resulting from such actions.
Page 3 - 132LR0267(03)
[DELETED:   P p a  T p p a e a o d o  O n m a f o d b t  A i t w n h o a o o p t n h o a o oDC]
[DELETED:  m a f o d b t i i t i i a r o e a o d  O n h o a o o D A o i s o m b p o i t s a t p o l r t m t s o f a l h c p a b l t n h o a o o m a h a a t p s t p a h r f a d e u t s m s a d n a t m s n t a t n]
[DELETED:   W t e c o a m a o p p p o t m i a m b p  A l h c p a b l t p n p o n h o a o o a a m s n t a t n h o a o o m o f n h o a o o]


================================================================================

Raw Text:
APPROVED CHAPTER
MAY 29, 2025 145
BY GOVERNOR PUBLIC LAW
STATE OF MAINE
_____
IN THE YEAR OF OUR LORD
TWO THOUSAND TWENTY-FIVE
_____
H.P. 449 - L.D. 710
An Act to Expand Access and Reduce Barriers to Access to Naloxone
Hydrochloride and Other Opioid Overdose-reversing Medications
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 22 MRSA §2353, sub-§2, as amended by PL 2023, c. 161, §3, is further
amended to read:
2. Prescription; possession; administration. The prescription, possession and
administration of naloxone hydrochloride or another opioid overdose-reversing medication
is governed by this subsection.
A. A health care professional may directly or by standing order prescribe naloxone
hydrochloride or another opioid overdose-reversing medication to an individual at risk
of experiencing an opioid-related drug overdose. Over-the-counter naloxone
hydrochloride or another opioid overdose-reversing medication approved for over-the-
counter dispensation by the federal Food and Drug Administration or its successor
organization may be provided or administered with or without a prescription.
A-1. A pharmacist may prescribe and dispense naloxone hydrochloride or another
opioid overdose-reversing medication in accordance with protocols established under
Title 32, section 13815 to an individual of any age at risk of experiencing an opioid-
related drug overdose. Over-the-counter naloxone hydrochloride or another opioid
overdose-reversing medication approved for over-the-counter dispensation by the
federal Food and Drug Administration or its successor organization may be provided
or administered with or without a prescription.
B. An individual to whom naloxone hydrochloride or another opioid overdose-
reversing medication is prescribed or dispensed in accordance with paragraph A or A‑1
may provide the naloxone hydrochloride or another opioid overdose-reversing
medication so prescribed or dispensed to a member of that individual's immediate
family to possess and administer to the individual if the family member believes in
good faith that the individual is experiencing an opioid-related drug overdose.
C. A health care professional may directly or by standing order prescribe naloxone
hydrochloride or another opioid overdose-reversing medication to a member of an
Page 1 - 132LR0267(03)

individual's immediate family or a friend of the individual or to another person in a
position to assist the individual if the individual is at risk of experiencing an opioid-
related drug overdose. Over-the-counter naloxone hydrochloride or another opioid
overdose-reversing medication approved for over-the-counter dispensation by the
federal Food and Drug Administration or its successor organization may be provided
or administered with or without a prescription.
C-1. A pharmacist may prescribe and dispense naloxone hydrochloride or another
opioid overdose-reversing medication in accordance with protocols established under
Title 32, section 13815 to a person of any age who is a member of an individual's
immediate family or a friend of the individual or to another person in a position to assist
the individual if the individual is at risk of experiencing an opioid-related drug
overdose. Over-the-counter naloxone hydrochloride or another opioid overdose-
reversing medication approved for over-the-counter dispensation by the federal Food
and Drug Administration or its successor organization may be provided or
administered with or without a prescription.
D. If a member of an individual's immediate family, friend of the individual or other
person is prescribed or provided naloxone hydrochloride or another opioid overdose-
reversing medication in accordance with paragraph C or C‑1, that family member,
friend or other person may administer the naloxone hydrochloride or another opioid
overdose-reversing medication to the individual if the family member, friend or other
person believes in good faith that the individual is experiencing an opioid-related drug
overdose.
Nothing in this subsection affects the provisions of law relating to maintaining the
confidentiality of medical records.
Sec. 2. 22 MRSA §2353, sub-§4, as amended by PL 2023, c. 71, §1 and c. 161, §3,
is further amended to read:
4. Community-based drug overdose prevention programs; standing orders for
naloxone hydrochloride or another opioid overdose-reversing medication. Acting
under standing orders from a licensed health care professional authorized by law to
prescribe naloxone hydrochloride or another opioid overdose-reversing medication, a
public health an agency that provides services to populations at high risk for a drug
overdose may establish an overdose prevention program in accordance with rules adopted
by the department and the provisions of this subsection.
A. Notwithstanding any provision of law to the contrary, an overdose prevention
program established under this subsection may store and dispense naloxone
hydrochloride or another opioid overdose-reversing medication without being subject
to the provisions of Title 32, chapter 117 as long as these activities are undertaken
without charge or compensation.
B. An overdose prevention program established under this subsection may distribute
unit-of-use packages of naloxone hydrochloride or another opioid overdose-reversing
medication and the medical supplies necessary to administer the naloxone
hydrochloride or another opioid overdose-reversing medication to a person who has
successfully completed training provided by the overdose prevention program that
meets the protocols and criteria established by the department, so that the person may
possess and administer naloxone hydrochloride or another opioid overdose-reversing
Page 2 - 132LR0267(03)

medication to an individual who appears to be experiencing an opioid-related drug
overdose.
C. With the express consent of a municipality, an overdose prevention program
established under this subsection may provide and maintain naloxone hydrochloride or
another opioid overdose-reversing medication in a wall-mounted box or other visible
and accessible container, including, but not limited to, a vending machine, on publicly
accessible property of the municipality, including a municipal building, public
restroom, public library or public park or recreational facility, for use by a member of
the public in response to an opioid-related drug overdose.
The department shall adopt rules to implement this subsection. Rules adopted pursuant to
this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter
2‑A.
Sec. 3. 22 MRSA §2353, sub-§4-A, ¶B, as amended by PL 2023, c. 161, §3, is
repealed.
Sec. 4. 22 MRSA §2353, sub-§4-A, ¶C, as amended by PL 2023, c. 161, §3, is
further amended to read:
C. A licensed health care professional authorized by law to prescribe naloxone
hydrochloride or another opioid overdose-reversing medication shall distribute unit-
of-use packages of naloxone hydrochloride or another opioid overdose-reversing
medication and any medical supplies necessary to administer the naloxone
hydrochloride or another opioid overdose-reversing medication to a recovery residence
that has provided training described in paragraph B so that the recovery residence may
possess and administer naloxone hydrochloride or another opioid overdose-reversing
medication to an individual who appears to be experiencing a drug-related overdose.
Sec. 5. 22 MRSA §2353, sub-§5, ¶C, as enacted by PL 2023, c. 71, §2, is amended
to read:
C. A municipality or overdose prevention program is immune from criminal and civil
liability for providing or maintaining naloxone hydrochloride containers or containers
of another opioid overdose-reversing medication under subsection 4, paragraph C.
Sec. 6. 22 MRSA §2353, sub-§5, ¶D, as enacted by PL 2023, c. 154, §2, is
amended to read:
D. A person not described in this section as being authorized to possess, obtain, store,
administer or dispense naloxone hydrochloride or another opioid overdose-reversing
medication or a person, notwithstanding any provision of law to the contrary, acting in
good faith and with reasonable care, is immune from criminal and civil liability and is
not subject to professional or other disciplinary action for providing to another person
naloxone hydrochloride or another opioid overdose-reversing medication, or for
administering naloxone hydrochloride or another opioid overdose-reversing
medication to an individual whom the person believes in good faith is experiencing an
opioid-related drug overdose or for any outcome resulting from such actions.
Page 3 - 132LR0267(03)

[DELETED:   P p a  T p p a e a o d o  O n m a f o d b t  A i t w n h o a o o p t n h o a o oDC]
[DELETED:  m a f o d b t i i t i i a r o e a o d  O n h o a o o D A o i s o m b p o i t s a t p o l r t m t s o f a l h c p a b l t n h o a o o m a h a a t p s t p a h r f a d e u t s m s a d n a t m s n t a t n]
[DELETED:   W t e c o a m a o p p p o t m i a m b p  A l h c p a b l t p n p o n h o a o o a a m s n t a t n h o a o o m o f n h o a o o]